The object of this study was the identification of brain areas that were significantly more connected than other regions with a previously identified reference region, the posterior cingulate cortex, during the presentation of visual cues in alcoholics. Alcohol-related and neutral video sequences were presented to 30 alcoholics who had been abstinent for at least 4 days. Participants underwent a psychometric assessment before and after the presentation of the video sequences. Functional MRI data were acquired. Psychophysiological interaction analyses were carried out. Participants reported a significant increase in craving and arousal after the presentation of alcohol-related video sequences. The simple contrast alcohol versus neutral was found not to be significantly different in the present study. The brain regions that were found to correlate significantly more with the posterior cingulate cortex under the alcohol-related condition were the inferior parietal lobe, the medial temporal lobe, the inferior frontal gyrus, the postcentral gyrus, and the precuneus. The involvement of these regions in processes of memory, self-control, and self-reflection with a particular focus on alcohol dependence and craving will be discussed.

Keywords:
Abstinent alcoholics, Alcohol-related stimuli, Posterior cingulate cortex, Perceived stress scale, Craving
1.
Singleton EG, Gorelick DA: Mechanisms of alcohol craving and their clinical implications. Recent Dev Alcohol 1998;14:177-195.
2.
Verheul R, van den Brink W, Geerlings P: A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 1999;34:197-222.
3.
Anton RF: What is craving? Models and implications for treatment. Alcohol Res Health 1999;23:165-173.
4.
von der Goltz C, Kiefer F: Learning and memory in the aetiopathogenesis of addiction: future implications for therapy? Eur Arch Psychiatry Clin Neurosci 2009;259(suppl 2):S183-S187.
5.
Ludwig AM, Wikler A: ‘Craving' and relapse to drink. Q J Stud Alcohol 1974;35:108-130.
6.
Tiffany ST: A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev 1990;97:147-168.
7.
Veltrup C: Assessment of ‘craving' in alcoholic patients using a new questionnaire (Lubeck craving-Recurrence Risk Questionnaire) (in German). Wien Klin Wochenschr 1994;106:75-79.
8.
Schacht JP, Anton RF, Myrick H: Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 2013;18:121-133.
9.
Grusser SM, Heinz A, Flor H: Standardized stimuli to assess drug craving and drug memory in addicts. J Neural Transm 2000;107:715-720.
10.
Schoenmakers TM, Wiers RW: Craving and attentional bias respond differently to alcohol priming: a field study in the pub. Eur Addict Res 2010;16:9-16.
11.
Khazaal Y, Zullino D, Billieux J: The Geneva smoking pictures: development and preliminary validation. Eur Addict Res 2012;18:103-109.
12.
Vollstadt-Klein S, Loeber S, Winter S, Lemenager T, von der Goltz C, Dinter C, Koopmann A, Wied C, Winterer G, Kiefer F: Attention shift towards smoking cues relates to severity of dependence, smoking behavior and breath carbon monoxide. Eur Addict Res 2011;17:217-224.
13.
Papachristou H, Nederkoorn C, Corstjens J, Jansen A: The role of impulsivity and perceived availability on cue-elicited craving for alcohol in social drinkers. Psychopharmacology (Berl) 2012;224:145-153.
14.
Khalili-Mahani N, Zoethout RM, Beckmann CF, Baerends E, de Kam ML, Soeter RP, Dahan A, van Buchem MA, van Gerven JM, Rombouts SA: Effects of morphine and alcohol on functional brain connectivity during ‘Resting state': a placebo-controlled crossover study in healthy young men. Hum Brain Mapp 2012;33:1003-1018.
15.
Beck A, Wustenberg T, Genauck A, Wrase J, Schlagenhauf F, Smolka MN, Mann K, Heinz A: Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Arch Gen Psychiatry 2012;69:842-852.
16.
O'Reilly JX, Woolrich MW, Behrens TE, Smith SM, Johansen-Berg H: Tools of the trade: psychophysiological interactions and functional connectivity. Soc Cogn Affect Neurosci 2012;7:604-609.
17.
Vollstadt-Klein S, Loeber S, Kirsch M, Bach P, Richter A, Buhler M, von der Goltz C, Hermann D, Mann K, Kiefer F: Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. Biol Psychiatry 2011;69:1060-1066.
18.
Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS: Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 2004;29:393-402.
19.
Langosch JM, Spiegelhalder K, Jahnke K, Feige B, Regen W, Kiemen A, Hennig J, Olbrich HM: The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study. J Clin Psychopharmacol 2012;32:661-665.
20.
World Health Organization: International Classification of Diseases (ICD-10). Geneva, World Health Organization, 1994.
21.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
22.
Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW: Assessment of the alcohol withdrawal syndrome-validity and reliability of the translated and modified clinical institute withdrawal assessment for alcohol scale (CIWA-A). Addiction 1994;89:1287-1292.
23.
DiClemente CC, Carbonari JP, Montgomery RP, Hughes SO: The alcohol abstinence self-efficacy scale. J Stud Alcohol 1994;55:141-148.
24.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
25.
Cohen S, Kamarck T, Mermelstein R: A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
26.
Bradley MM, Lang PJ: Measuring emotion: the self-assessment manikin and the semantic differential. J Behav Ther Exp Psychiatry 1994;25:49-59.
27.
Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System - An Approach to Cerebral Imaging. New York, Thieme, 1988.
28.
Schneider F, Habel U, Wagner M, Franke P, Salloum JB, Shah NJ, Toni I, Sulzbach C, Honig K, Maier W, Gaebel W, Zilles K: Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry 2001;158:1075-1083.
29.
Vann SD, Aggleton JP, Maguire EA: What does the retrosplenial cortex do? Nat Rev Neurosci 2009;10:792-802.
30.
Summerfield JJ, Hassabis D, Maguire EA: Cortical midline involvement in autobiographical memory. Neuroimage 2009;44:1188-1200.
31.
Sugiura M, Shah NJ, Zilles K, Fink GR: Cortical representations of personally familiar objects and places: functional organization of the human posterior cingulate cortex. J Cogn Neurosci 2005;17:183-198.
32.
Maddock RJ, Garrett AS, Buonocore MH: Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task. Hum Brain Mapp 2003;18:30-41.
33.
Boening JA: Neurobiology of an addiction memory. J Neural Transm 2001;108:755-765.
34.
Park MS, Sohn JH, Suk JA, Kim SH, Sohn S, Sparacio R: Brain substrates of craving to alcohol cues in subjects with alcohol use disorder. Alcohol Alcohol 2007;42:417-422.
35.
Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA: Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000;157:1789-1798.
36.
Baars BJ, Gage N: Cognition, Brain, and Consciousness. Introduction to Cognitive Neuroscience. Oxford, Elsevier, 2010, pp 144-149.
37.
Baars BJ, Franklin S: How conscious experience and working memory interact. Trends Cogn Sci 2003;7:166-172.
38.
Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Wedeen VJ, Sporns O: Mapping the structural core of human cerebral cortex. PLoS Biol 2008;6:e159.
39.
Beauchamp MS: See me, hear me, touch me: multisensory integration in lateral occipital-temporal cortex. Curr Opin Neurobiol 2005;15:145-153.
40.
Everitt BJ, Robbins TW: Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005;8:1481-1489.
41.
Christopoulos GI, Tobler PN, Bossaerts P, Dolan RJ, Schultz W: Neural correlates of value, risk, and risk aversion contributing to decision making under risk. J Neurosci 2009;29:12574-12583.
42.
Aron AR, Robbins TW, Poldrack RA: Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004;8:170-177.
43.
Mainz V, Druke B, Boecker M, Kessel R, Gauggel S, Forkmann T: Influence of cue exposure on inhibitory control and brain activation in patients with alcohol dependence. Front Hum Neurosci 2012;6:92.
44.
Rangaswamy M, Porjesz B, Chorlian DB, Wang K, Jones KA, Bauer LO, Rohrbaugh J, O'Connor SJ, Kuperman S, Reich T, Begleiter H: Beta power in the EEG of alcoholics. Biol Psychiatry 2002;52:831-842.
45.
Coutin-Churchman P, Moreno R, Anez Y, Vergara F: Clinical correlates of quantitative EEG alterations in alcoholic patients. Clin Neurophysiol 2006;117:740-751.
46.
Bauer LO: Electroencephalographic and autonomic predictors of relapse in alcohol-dependent patients. Alcohol Clin Exp Res 1994;18:755-760.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.